VIA
PTX

Vantage Investment Advisors’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Vantage Investment Advisors’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-64
Closed – – 881
2016
Q2 		$0 Hold
64
– – ﹤0.01% 927
2016
Q1 		$1K Buy
+64
New +$1.27K ﹤0.01% 791

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Vantage Investment Advisors's PTX Position: Q3 2016 in Review

Vantage Investment Advisors sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2016, closing a stake of 64 shares.

Vantage Investment Advisors first reported a position in PTX in Q1 2016 and held it in 2 quarters. The position peaked at $1K in Q1 2016. 48 funds tracked by Wall St. Rank hold PTX as of Q3 2016.

  • Vantage Investment Advisors reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
  • Vantage Investment Advisors sold 64 Pernix Therapeutics Holdings, Inc. shares in Q3 2016.
  • Vantage Investment Advisors first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2016 and held it in 2 quarters.
  • Vantage Investment Advisors's Pernix Therapeutics Holdings, Inc. position peaked at $1K in Q1 2016.
  • 48 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2016.

Based on Vantage Investment Advisors's 13F filing for Q3 2016, filed 9 Nov 2016.